TP53 and cholestasis: Platinum-based drugs (e.g., cisplatin) target proximal tubule epithelial cells in the liver, inducing cholestasis via p53-mediated apoptosis and ATPase inhibition, which forms a “toxic cascade” with AMI-induced hepatic ischemia and hypoxia (Xu et al., 2021).